Irum Noor, DO
Allergy & Immunology · Manhasset, NYNPI 1811309933
Payments from drug & device makers
Across 334 payments — averaging $54.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alk-abello, Inc$10K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$2K
- GSK$1K
- Optinose US, Inc.$597
- Takeda Pharmaceuticals U.S.A., Inc.$326
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$7,55041%
- Travel & lodging$1,7309%
- Food & beverage$9,00449%
- Education$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alk-abello, Inc | 16 | $9,584 |
| Regeneron Healthcare Solutions, Inc. | 77 | $2,389 |
| Sanofi | 59 | $2,032 |
| GSK | 49 | $1,100 |
| Optinose US, Inc. | 24 | $597 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $326 |
| Kaleo, Inc. | 13 | $270 |
| Amgen | 9 | $257 |
| Incyte Corporation | 3 | $247 |
| AstraZeneca | 11 | $210 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $185 |
| Pfizer | 5 | $106 |
| Grifols USA, LLC | 5 | $101 |
| Dermavant Sciences, Inc. | 1 | $73 |
| Medtronic | 2 | $72 |
| Lilly USA, LLC | 3 | $70 |
| Sanofi-aventis U.S. LLC | 1 | $65 |
| Aimmune Therapeutics, Inc. | 3 | $61 |
| Hikma Pharmaceuticals USA | 3 | $59 |
| CSL Behring | 2 | $58 |
| Genentech USA, Inc. | 3 | $57 |
| Novartis | 2 | $54 |
| Inspire Medical Systems, Inc. | 2 | $46 |
| Phadia US Inc. | 2 | $42 |
| AbbVie | 2 | $42 |
| EPI Health, LLC | 1 | $40 |
| Octapharma USA, Inc. | 2 | $39 |
| Stryker | 2 | $37 |
| Aytu Biopharma, Inc. | 2 | $37 |
| Acclarent, Inc | 1 | $35 |
| Tersera Therapeutics LLC | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Neos Therapeutics, LP | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,356 in reported general payments places this provider in the 75th percentile of 320 allergy & immunology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 36 | $131,763 |
| Ipratropium Bromide | 30 | $525 |
| Azelastine Hcl | 15 | $238 |
| Levocetirizine Dihydrochloride | 12 | $45 |
| Montelukast Sodium | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Manhasset
- Robert CorrielManhasset$24K
- Peter DeaneRochester$3.7M
- Syed MustafaRochester$3.6M
- Golda HudesBronx$2.4M
- Arye RubinsteinBronx$1.1M
- Ujwala KazaNew York$1.1M
- Robert SporterNew York$980K
- Mili ShumWest Harrison$924K
- Paula BusseNew York$821K
- Gregory PuglisiPlainview$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.